Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (451-460 of 942) with videos related to

Pageof 95
Sort By:
Journal of the American College of Cardiology|November 3, 2004
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosisRajat Deo, Amit Khera, Darren K McGuire, et al.
Circulation|January 31, 2016
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)Marc P Bonaca, J Antonio Gutierrez, Mark A Creager, et al.
Circulation|April 14, 2010
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36)Jessica L Mega, Judith S Hochman, Benjamin M Scirica, et al.
Environmental Health Perspectives|March 1, 1997
Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicalsI R Bell, J Rossi, M E Gilbert, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Evaluation of a clinical pathway for sedation and analgesia of mechanically ventilated patients in a cardiac intensive care unit (CICU): The Brigham and Women's Hospital Levine CICU sedation pathwaysAaron W Aday, Heather Dell'orfano, Beth A Hirning, et al.
Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.
JAMA Pediatrics|January 10, 2017
Variation in Performance of Neonatal Intensive Care Units in the United StatesJeffrey D Horbar, Erika M Edwards, Lucy T Greenberg, et al.
International Journal of Cardiology|January 12, 2008
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromesShaheeda Ahmed, Christopher P Cannon, Robert P Giugliano, et al.
European Heart Journal. Acute Cardiovascular Care|April 13, 2019
Incremental costs of high intensive care utilisation in patients hospitalised with heart failureSean van Diepen, Dat T Tran, Justin A Ezekowitz, et al.
European Heart Journal. Acute Cardiovascular Care|December 25, 2014
Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36Marc P Bonaca, Ryan G O'Malley, Sabina A Murphy, et al.
Pageof 95

Showing results (451-460 of 942) with videos related to

Sort By:
Pageof 95
Journal of the American College of Cardiology|November 3, 2004
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosisRajat Deo, Amit Khera, Darren K McGuire, et al.
Circulation|January 31, 2016
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)Marc P Bonaca, J Antonio Gutierrez, Mark A Creager, et al.
Circulation|April 14, 2010
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36)Jessica L Mega, Judith S Hochman, Benjamin M Scirica, et al.
Environmental Health Perspectives|March 1, 1997
Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicalsI R Bell, J Rossi, M E Gilbert, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Evaluation of a clinical pathway for sedation and analgesia of mechanically ventilated patients in a cardiac intensive care unit (CICU): The Brigham and Women's Hospital Levine CICU sedation pathwaysAaron W Aday, Heather Dell'orfano, Beth A Hirning, et al.
Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.
JAMA Pediatrics|January 10, 2017
Variation in Performance of Neonatal Intensive Care Units in the United StatesJeffrey D Horbar, Erika M Edwards, Lucy T Greenberg, et al.
International Journal of Cardiology|January 12, 2008
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromesShaheeda Ahmed, Christopher P Cannon, Robert P Giugliano, et al.
European Heart Journal. Acute Cardiovascular Care|April 13, 2019
Incremental costs of high intensive care utilisation in patients hospitalised with heart failureSean van Diepen, Dat T Tran, Justin A Ezekowitz, et al.
European Heart Journal. Acute Cardiovascular Care|December 25, 2014
Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36Marc P Bonaca, Ryan G O'Malley, Sabina A Murphy, et al.
Pageof 95